Sara Zamani

Oral contraceptive and menopausal hormone therapy use and risk of pancreatic cancer: a systematic review, meta-analysis, and dose–response analysis

Pancreatic cancer has a poor prognosis, and hormonal factors have been proposed as potential modifiers of risk. However, the association between exogenous female hormone use and pancreatic cancer remains uncertain. We conducted a comprehensive systematic review and meta-analysis...